Rejuvenate Biomed

3:00 PM - 3:15 PM (EDT), Monday, June 5, 2023 ・ Session Room 104C
Rejuvenate Biomed is an independent Belgian biomedical company established in October 2017 by Ann Beliën, PhD, after nearly two decades of experience with Janssen Pharmaceutical companies of Johnson & Johnson. The company is developing safe, proprietary, combination drugs that delay or prevent the onset of multiple age-related diseases, with a focus on the intersection between fundamental aging mechanisms and chronic conditions.
Company Type:
Privately Funded Company
Company HQ State:
Not Provided
Company HQ Country:
Belgium
Year Founded:
2017
Main Therapeutic Focus:
Multiple Therapeutics
Lead Product in Development:
RJx-01
Development Phase of Primary Product:
Phase II
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
Founder & CEO
Rejuvenate Biomed